Quoin Pharmaceuticals (QNRX) Liabilities and Shareholders Equity (2016 - 2026)
Quoin Pharmaceuticals' Liabilities and Shareholders Equity came in at $11.97 million for the quarter ended Jun 30, 2026, up 34.3% from $8.91 million a year earlier but down 23.7% from the prior quarter.
Powered by 
Analysis
Quoin Pharmaceuticals (QNRX) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends
As of Dec 31, 2025, Quoin Pharmaceuticals' Liabilities and Shareholders Equity was $20.39 million, up 29.8% from the prior year.
- Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 71.4% (years ended Dec 2020 to Dec 2025).
- Going back by year, Liabilities and Shareholders Equity was $15.71 million in the year ended Dec 31, 2024 (+29.1%), $12.17 million in the year ended Dec 31, 2023 (-15.8%), $14.46 million in the year ended Dec 31, 2022 (+54.5%) and $9.36 million in the year ended Dec 31, 2021 (+579.1%).
- The five-year range for quarterly Liabilities and Shareholders Equity is $4.32 million (the quarter ended Jun 30, 2022) to $20.39 million (the quarter ended Dec 31, 2025).
- Year-over-year, Liabilities and Shareholders Equity has increased for three consecutive quarters, with an average decline of 1.2% over the last eight quarters.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in the quarter ended Dec 31, 2021 (growth of 579.1%), and the weakest in the quarter ended Sep 30, 2025 (a decline of 43.6%).
- Business Quant data shows QNRX's Liabilities and Shareholders Equity at $15.69 million (quarter ended Mar 31, 2026), $20.39 million (quarter ended Dec 31, 2025) and $6.42 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.82 Bn | 1,126.40 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 625.08 Bn | 543.61 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 509.83 Bn | 482.94 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.85 Bn | 320.23 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 296.26 Bn | 260.25 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 260.41 Bn | 234.09 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 235.13 Bn | 190.53 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 192.91 Bn | 167.10 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.83 Bn | 117.47 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Quoin Pharmaceuticals | 330,236.94 | -45.13 Mn | - | 11.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.97 Mn |
| Mar 31, 2026 | 15.69 Mn |
| Dec 31, 2025 | 20.39 Mn |
| Sep 30, 2025 | 6.42 Mn |
| Jun 30, 2025 | 8.91 Mn |
| Mar 31, 2025 | 12.96 Mn |
| Dec 31, 2024 | 15.71 Mn |
| Sep 30, 2024 | 11.39 Mn |
| Jun 30, 2024 | 14.05 Mn |
| Mar 31, 2024 | 16.12 Mn |
| Dec 31, 2023 | 12.17 Mn |
| Sep 30, 2023 | 15.07 Mn |
| Jun 30, 2023 | 16.71 Mn |
| Mar 31, 2023 | 18.45 Mn |
| Dec 31, 2022 | 14.46 Mn |
| Sep 30, 2022 | 16.44 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Dec 31, 2021 | 9.36 Mn |
| Dec 31, 2020 | 6.09 Mn |
| Jun 30, 2020 | 8.02 Mn |
API Access
Quoin Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=QNRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "QNRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=QNRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();